Founders Financial Alliance, LLC Amgen Inc Transaction History

Founders Financial Alliance, LLC

$352 Million
Q3 2024

A detailed history of Founders Financial Alliance, LLC transactions in Amgen Inc stock. As of the latest transaction made, Founders Financial Alliance, LLC holds 2,545 shares of AMGN stock, worth $667,375. This represents 0.23% of its overall portfolio holdings.

Number of Shares

2,545

Previous 2,568 0.9%

Holding current value

$667,375

Previous $802,000 2.24%

% of portfolio

0.23%

Previous 0.24%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$309.38 - $337.38 $7,115 - $7,759	-23 Reduced 0.9%	2,545 $820,000
Q2 2024 Aug 23, 2024	BUY	$262.75 - $319.31 $22,071 - $26,822	84 Added 3.38%	2,568 $802,000
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $18,820 - $22,719	70 Added 2.9%	2,484 $706,000
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $1,022 - $1,153	4 Added 0.17%	2,414 $695,000
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $232,643 - $288,833	-1,064 Reduced 30.63%	2,410 $647,000
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $463,680 - $548,292	2,164 Added 165.19%	3,474 $771,000
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $23,030 - $28,070	-102 Reduced 7.22%	1,310 $316,000
Q4 2022 Feb 15, 2023	SELL	$229.03 - $291.01 $65,502 - $83,228	-286 Reduced 16.84%	1,412 $370,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $75,418 - $85,058	336 Added 24.67%	1,698 $383,000
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $61,368 - $68,292	-266 Reduced 16.34%	1,362 $331,000
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $877 - $970	-4 Reduced 0.25%	1,628 $394,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $2,585 - $2,958	-13 Reduced 0.79%	1,632 $367,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $41,180 - $48,247	-194 Reduced 10.55%	1,645 $349,000
Q2 2021 Aug 02, 2021	BUY	$233.58 - $259.14 $8,175 - $9,069	35 Added 1.94%	1,839 $448,000
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $203,935 - $237,653	-919 Reduced 33.75%	1,804 $455,000
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $305,744 - $364,087	1,413 Added 107.86%	2,723 $623,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $307,391 - $341,844	1,310 New	1,310 $322,000

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

407M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Alliance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Alliance, LLC with notifications on news.

Account

Founders Financial Alliance, LLC Amgen Inc Transaction History